RPE65 and retinal degeneration: One study used CRISPR–Cas9 to correct a nonsense mutation in the RPE65 gene in a mouse LCA model of type 12 (rd12) retinal degeneration, resulting in homology‐directed repair of RPE65 in mouse retinal pigment epithelial tissues, and achieving therapeutic correction in RPE65 mutations.350